Global Oligonucleotide Therapy Market
Pharmaceuticals

Global Oligonucleotide Therapy Market Size, Share, Trends And Drivers 2023-2032

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest oligonucleotide therapy market share in 2022.

The global oligonucleotide therapy market is expected to grow from $1.1 billion in 2022 to $1.23 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%. The oligonucleotide therapy market is expected to grow from $2.1 billion in 2027 at a CAGR of 14.2%.

Major Driver In The Oligonucleotide Therapy Market ­– Rise In The Number Of Cancer Cases
According to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the United States in January 2022, or around 1,670 deaths each day. Lung, prostate, bowel, and female breast cancer are the four most frequent kinds of cancer worldwide, accounting for 43 percent of all new cancer cases. Lung, prostate, bowel, and female breast cancer are the four most frequent kinds of cancer worldwide, accounting for 43 percent of all new cancer cases.

View More On The Oligonucleotide Therapy Market Report 2023- https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Key Oligonucleotide Therapy Market Segments
1) By Type: Antisense Oligonucleotide, Aptamer, Other Types
2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User
3) By End User: Hospitals, Research Institutes

Recent Oligonucleotide Therapy Market Trend – Investing in Research and Development to Remodel the Design of Therapy
The novel and unique oligonucleotides enable precision medicine approaches by allowing for the specific targeting of any gene with minimum adverse effects. It also aids in the identification of patient-specific sequences that are responsible for uncommon disorders. Viltepso (viltolarsen) injection, an antisense oligonucleotide for the treatment of Duchenne muscular dystrophy (DMD), a hereditary condition, received accelerated approval from the FDA in August 2020.

Oligonucleotide Therapy Market Prominent Players
Major players in the oligonucleotide therapy market are Alnylam Pharmaceuticals Inc., Biogen Inc., Dynavax Technologies Corp., Ionis Pharmaceuticals Inc., Merck & Co. Inc., Miragen Therapeutics Inc., PCI Biotech Holdings ASA, Sarepta Therapeutics Inc., Jazz Pharmaceuticals and Bausch & Lomb.

Request A Sample Of The Global Oligonucleotide Therapy Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

The Oligonucleotide Therapy Global Market Report 2023  provides a comprehensive overview on the oligonucleotide therapy market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the oligonucleotide therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Oligonucleotide therapy refers to a collective term for cutting-edge molecular-targeting agents that use chemically produced oligonucleotides with single-stranded DNA (DNA) or RNA (RNA) backbones that have the potential for selectivity. Oligonucleotides are made to base-pair with a strand of DNA or RNA for the majority of applications. PCR primers are oligonucleotides’ most popular application (polymerase chain reaction).

View More Related Reports –
Drugs For Hormonal Replacement Therapy Global Market Report 2023
Nucleic Acid Based Gene Therapy Global Market Report 2023
Convalescent Plasma Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:
https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model